Agile Outcomes Research Inc is categorized under Commercial Medical Research in Rochester, MN and active since 2009.
Agile Outcomes Research Inc was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Mike Stensland at the company’s single location by writing to 3560 Nebula Lane Sw, Rochester, Minnesota MN 55902 or by phoning (317) 294-0927. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Agile Outcomes Research Inc |
| Contact Person: | Mike Stensland |
| Address: | 3560 Nebula Lane Sw, Rochester, Minnesota 55902 |
| Phone Number: | (317) 294-0927 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Agile Outcomes Research Inc was started in 2009 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Mike Stensland for inquiries that concern Agile Outcomes Research Inc by calling the company number (317) 294-0927, as your correspondence is most welcome. Additionally, the physical location of the single location of Agile Outcomes Research Inc can be found at the coordinates as well as the street address 3560 Nebula Lane Sw in Rochester, Minnesota 55902.
For its online presence, you may visit Agile Outcomes Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.